Abbott Labs

As the market begins to shift its focus away from tech, CNBC’s Jim Cramer has identified several potential winners, CNBC reports. Cramer has highlighted a few sectors that could benefit from this shift. He believes that the market is currently in a “stock picker’s market”...

The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Abbott Laboratories (NYSE: ABT) traded today at a new 52-week high of $129.40. Approximately 642,000 shares have changed hands today, as...

Short interest in many leading biotech stocks tumbled in the most recent period. Amgen, Inc. (NASDAQ: AMGN), Biogen Inc (NASDAQ: BIIB) and Celgene Corporation (NASDAQ: CELG) saw sharp drops in their short interest in late October. A few biotech stocks did see a modest bump in the number shares...

Short interest changes in biotech stocks were mixed during the most recent period. Baxalta Inc (NYSE: BXLT) and Juno Therapeutics Inc (NASDAQ: JUNO) saw short interest surges in late September. Short interest in Medivation Inc (NASDAQ: MDVN) plunged during that time. With the ongoing market...

This weekend in Barron's online: the fall Big Money poll results, as well as the prospects for AT&T, Outerwall, Questcor Pharmaceuticals and more. Cover Story "Raking In Returns" by Jack Willoughby. American money managers expect stocks to rise seven percent between now and the middle of...

If somebody asked you to explain risk/reward, what would you say? You’d probably say that it tells you if there’s enough upside profit potential to justify the risk. You’re right, but how do you know? Did you know that risk/reward is a calculation and professional traders would tell you that if...

Slow economic growth like the United States is experiencing now is ideal for secular growth stocks. Bank of America defines secular growth in part as companies with earnings that have lower than average variability, as well as a forecast for between 10 percent and 20 percent earnings growth over...